Gladys Villas Boas Do Prado

Gladys Villas Boas Do Prado

Auto-generated profile, based on publicly available information

Gladys Villas Boas Do Prado

Laboratório de Investigação Médica 54 (LIM-54), Instituto de Medicina Tropical, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in The Lancet HIV
Verified
Journal Article
Closed access
BGBeatriz Grinsztejn
Beatriz Grinsztejn
BHBrenda Hoagland
Brenda Hoagland
RMRonaldo I Moreira
Ronaldo I Moreira
EKEsper G Kallas
Esper G Kallas
JMJose V Madruga
Jose V Madruga
NZNélio Zuccaro
Nélio Zuccaro

13 March 2008 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MOM. S. Oliveira
M. S. Oliveira
GPG. V. B. Prado
G. V. B. Prado
SCS. F. Costa
S. F. Costa
RGR. S. Grinbaum
R. S. Grinbaum
ALA. S. Levin
A. S. Levin
There has been an increase in worldwide infections caused by carbapenem-resistant Acinetobacter. This poses a therapeutic challenge as few treatment options are available. The aim of this study was to evaluate the efficacy and safety of polymyxins and ampicillin/sulbactam for treating infections caused by carbapenem-resistant Acinetobacter spp. and to evaluate prognostic factors. This was a retrospective review of patients from two teaching hospitals who had nosocomial infections caused by carbapenem-resistant Acinetobacter spp. from 1996 to 2004. Diagnosis of infection was based on CDC criteria plus the isolation of Acinetobacter from a usually sterile site or from bronchoalveolar lavage. Urinary tract infections were not included. Data on demographic and clinical features and treatment were collected from medical records. Prognostic factors associated with two outcomes (mortality during treatment and in-hospital mortality) were evaluated. Eighty-two patients received polymyxins and 85 were treated with ampicillin/sulbactam. Multiple logistic regression analysis revealed that independent predictors of mortality during treatment were treatment with polymyxins, higher Acute Physiological and Chronic Health Evaluation II (APACHE II) score, septic shock, delay in starting treatment and renal failure. On multivariate analysis, prognostic factors for in-hospital mortality were older age, septic shock and higher APACHE II score. This is the first study comparing current therapeutic options for infections due to carbapenem-resistant Acinetobacter. The most important finding of the present study is that ampicillin/sulbactam appears to be more efficacious than polymyxins, which was an independent factor associated with mortality during treatment.

1 December 2009 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
MOMaura S. Oliveira
Maura S. Oliveira
GPGladys V.B. Prado
Gladys V.B. Prado
SCSilvia F. Costa
Silvia F. Costa
RGRenato S. Grinbaum
Renato S. Grinbaum
ALAnna S. Levin
Anna S. Levin

1 February 2015 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
MOM.S. de Oliveira
M.S. de Oliveira
DAD.B. de Assis
D.B. de Assis
MFMaristela p freire
Maristela p freire
GPG.V. Boas Do Prado
G.V. Boas Do Prado
AMA.S. Machado
A.S. Machado
ALA.S. Levin
A.S. Levin

1 November 2016 in American Journal of Infection Control
Verified
Journal Article
Closed access
TGThaís Guimarães
Thaís Guimarães
ECErica Chimara
Erica Chimara
GPGladys Villas Boas Do Prado
Gladys Villas Boas Do Prado
LFLucilaine Ferrazoli
Lucilaine Ferrazoli
NCNatalia Garcia Fernandes Carvalho
Natalia Garcia Fernandes Carvalho
ALAnna S. Levin
Anna S. Levin

1 August 2013 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
HCHelio Hehl Caiaffa-Filho
Helio Hehl Caiaffa-Filho
PTPRISCILA de Arruda TRINDADE
PRISCILA de Arruda TRINDADE
PCPaula Gabriela da Cunha
Paula Gabriela da Cunha
CACecilia Salete Alencar
Cecilia Salete Alencar
GPGladys V.B. Prado
Gladys V.B. Prado
ALAnna S. Levin
Anna S. Levin